
OICR-supported research to help immunocompromised cancer patients get vaccinated
The Waterloo-based study will advance the use of a vaccine decision tool for healthcare professionals tailored to cancer patients’ needs. A research team at
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.